These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 3381319

  • 21. Sickle cell disease: the Lebanese experience.
    Inati A, Jradi O, Tarabay H, Moallem H, Rachkidi Y, El Accaoui R, Isma'eel H, Wehbe R, Mfarrej BG, Dabbous I, Taher A.
    Int J Lab Hematol; 2007 Dec; 29(6):399-408. PubMed ID: 17988293
    [Abstract] [Full Text] [Related]

  • 22. Molecular studies on Yemeni sickle-cell-disease patients: Xmn I polymorphism.
    el-Hazmi MA, Warsy AS.
    East Mediterr Health J; 1999 Nov; 5(6):1183-7. PubMed ID: 11924109
    [Abstract] [Full Text] [Related]

  • 23. [S hemoglobinopathies in Argentina].
    Abreu MS, Peñalver JA.
    Medicina (B Aires); 1992 Nov; 52(4):341-6. PubMed ID: 1340883
    [Abstract] [Full Text] [Related]

  • 24. The red cell distribution width in sickle cell disease--is it of clinical value?
    Thame M, Grandison Y, Mason K, Thompson M, Higgs D, Morris J, Serjeant B, Serjeant G.
    Clin Lab Haematol; 1991 Nov; 13(3):229-37. PubMed ID: 1794225
    [Abstract] [Full Text] [Related]

  • 25. Cardiovascular function during rest and exercise in patients with sickle-cell anemia and coexisting alpha thalassemia-2.
    Braden DS, Covitz W, Milner PF.
    Am J Hematol; 1996 Jun; 52(2):96-102. PubMed ID: 8638648
    [Abstract] [Full Text] [Related]

  • 26. Sickle cell disease in India.
    Kar BC.
    J Assoc Physicians India; 1991 Dec; 39(12):954-60. PubMed ID: 1816226
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of thalassaemias in ethnic Saudi Arabians.
    Ganeshaguru K, Acquaye JK, Samuel AP, Hassounah F, Agyeiobese S, Azrai LM, Sejeny SA, Omer A.
    Trop Geogr Med; 1987 Jul; 39(3):238-43. PubMed ID: 3433339
    [Abstract] [Full Text] [Related]

  • 28. Thalassaemia and glucose-6-phosphate dehydrogenase deficiency in sickle-cell disorder patients in Taiz, Yemen.
    Al-Nood HA.
    East Mediterr Health J; 2011 May; 17(5):404-8. PubMed ID: 21796953
    [Abstract] [Full Text] [Related]

  • 29. Effect of alpha-globin genotype on the pathophysiology of sickle cell disease.
    Ballas SK.
    Pediatr Pathol Mol Med; 2001 May; 20(2):107-21. PubMed ID: 12673836
    [Abstract] [Full Text] [Related]

  • 30. A study of alpha thalassaemia families in western Saudi Arabia.
    Acquaye J, Ganeshaguru K, Sejeny S, Selchouk S, Hassounah F, Samuel A, Omer A.
    Trop Geogr Med; 1985 Dec; 37(4):319-27. PubMed ID: 4095770
    [Abstract] [Full Text] [Related]

  • 31. Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia.
    el-Hazmi MA, Warsy AS.
    East Mediterr Health J; 1999 Nov; 5(6):1147-53. PubMed ID: 11924103
    [Abstract] [Full Text] [Related]

  • 32. Red cell distribution width in sickle cell disease.
    Webster P, Castro O.
    Ann Clin Lab Sci; 1986 Nov; 16(4):274-7. PubMed ID: 3740796
    [Abstract] [Full Text] [Related]

  • 33. [Sickle cell test: for all ethnic minorities?].
    Reichart M.
    Tijdschr Kindergeneeskd; 1988 Aug; 56(4):170-1. PubMed ID: 3176017
    [Abstract] [Full Text] [Related]

  • 34. Fibrocongestive splenomegaly in sickle cell disease: a distinct clinicopathological entity in the Eastern province of Saudi Arabia.
    Chopra R, Al-Mulhim AR, Al-Baharani AT.
    Am J Hematol; 2005 Jul; 79(3):180-6. PubMed ID: 15981225
    [Abstract] [Full Text] [Related]

  • 35. Inherited hemoglobin disorders in Guinea-Bissau, West Africa: a population study.
    Masmas TN, Garly ML, Lisse IM, Rodriques A, Petersen PT, Birgens H.
    Hemoglobin; 2006 Jul; 30(3):355-64. PubMed ID: 16840226
    [Abstract] [Full Text] [Related]

  • 36. [Ambulatory management of sickle cell disease: evaluation of the first year follow up of patients in the pediatric department of Lomé (Togo)].
    Gbadoé AD, Atsou K, Agbodjan-Djossou OA, Tsolényanu E, Nyadanu M, Dogba AD, Assimadi JK.
    Bull Soc Pathol Exot; 2001 May; 94(2):101-5. PubMed ID: 11475024
    [Abstract] [Full Text] [Related]

  • 37. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E, Multi-Center Study of Iron Overload Research Group.
    Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
    [Abstract] [Full Text] [Related]

  • 38. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
    Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, Kalinyak KA, Hudes M, Bhatia S, Vichinsky EP, Multi-Centre Study of Iron Overload Research Group.
    Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
    [Abstract] [Full Text] [Related]

  • 39. [Infections in Senegalese children and adolescents with sickle cell anemia: epidemiological aspects].
    Diagne I, Soares GM, Gueye A, Diagne-Gueye NR, Fall L, N'Diaye O, Camara B, Diouf S, Fall M.
    Dakar Med; 2000 Nov; 45(1):55-8. PubMed ID: 14666792
    [Abstract] [Full Text] [Related]

  • 40. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
    Darwish HM, El-Khatib FF, Ayesh S.
    Hemoglobin; 2005 Nov; 29(2):119-32. PubMed ID: 15921164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.